Pathologic Rupture of the Spleen in Mantle-Cell-Type Non-Hodgkin's Lymphoma.

Case Reports in Medicine
Christopher B TanPaul Mustacchia

Abstract

Mantle cell lymphoma (MCL) accounts for less than 10 percent of all non-Hodgkin's lymphoma (NHL). Pathologic or spontaneous rupture of the spleen has been reported in patients with lymphoma; however only 5 cases have been reported in patients with MCL. Although splenomegaly occurs frequently in patients with MCL, spontaneous splenic rupture is rare. We present a case of a 51-year-old female with MCL, who presented to the medical emergency room with splenic rupture. This case illustrates that clinicians should be aware of the incidence and presentation of patients with MCL and spontaneous splenic rupture, as early detection and heightened suspicion may prevent potentially fatal outcomes.

References

Apr 1, 1990·The British Journal of Surgery·J R DelperoY Carcassonne
Feb 3, 1986·The Medical Journal of Australia·J D GriffithsI A Cooper
Mar 1, 1995·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A J NortonT A Lister
Apr 1, 1994·Postgraduate Medical Journal·C C CroninC Hardiman
Dec 1, 1996·Annals of Hematology·A A GiagounidisW Schneider
May 9, 2001·Leukemia & Lymphoma·A H StricklandR M Lowenthal
Sep 27, 2003·The British Journal of Radiology·C GörgG Zugmaier
Oct 31, 2007·Acta chirurgica Belgica·J ChappuisP Mendes da Costa
Nov 3, 2009·Haematologica·Stefano A Pileri, Brunangelo Falini
Sep 10, 2010·Journal of Medical Case Reports·Michail Charakidis, David Joseph Russell

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
imaging techniques

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Related Papers

Applied Immunohistochemistry & Molecular Morphology : AIMM
Julie Teruya-FeldsteinCraig H Moskowitz
American Journal of Physical Medicine & Rehabilitation
Bonita SawatzkyAmira Tawashy
American Journal of Physical Medicine & Rehabilitation
R Samuel MayerSamuel C Durso
© 2021 Meta ULC. All rights reserved